Invitrocue

Invitrocue Limited is a provider of healthcare and personalised bio-analytics solutions.

[Invitrocue @Invitrocue]

Invitrocue Chief Scientific Officer, Dr. Zahra Dantes, will be presenting our latest findings on our current validation study regarding breast cancer at ESMO Breast Cancer 2022, 3-5 May, in Berlin.

Visit https://t.co/rh1gmCCwNP to register your interest.

[Invitrocue @Invitrocue]

Join us as Dr. Michael Wehr shares his expertise on High Content Pathway Profiling in Neurological Disease Models.
Find more information & Register here: https://t.co/eLXKFJRoTq

[Invitrocue @Invitrocue]

Join us as Dr. Chen Qing Feng shares his expertise in developing mouse models with various Human Biological Systems and the application.
Find more information & Register here: https://t.co/ogubpdyK11

[Invitrocue @Invitrocue]

Join us as Dr. Chen Qing Feng shares his expertise in developing mouse models with various Human Biological Systems and the application.
Find more information & Register here: https://t.co/ogubpdyK11

[Invitrocue @Invitrocue]

We're looking forward to the first Spain Symposium ! #oncology #PDO
New York, Canada Time: 10AM
Singapore, Hong Kong: 11PM
Register here: https://t.co/rDHM6OFGjP

[Invitrocue @Invitrocue]

We are 1 day away ! Join us to hear from Dr. Samuel Brennan from GenieUS about Development of Personalised Medicines for Sporadic ALS. Register here: https://t.co/Ljp9JUimGL
#ALS #Sporadic #PersonalisedMedicines

[Invitrocue @Invitrocue]

We are 1 day away ! Join us to hear from Dr. Samuel Brennan from GenieUS about Development of Personalised Medicines for Sporadic ALS. Register here: https://t.co/Ljp9JUimGL
#ALS #Sporadic #PersonalisedMedicines

[Invitrocue @Invitrocue]

We're looking forward to the first Spain Symposium ! #oncology #PDO
New York, Canada Time: 10AM
Singapore, Hong Kong: 11PM
Register here: https://t.co/rDHM6OFGjP

[Invitrocue @Invitrocue]

Join us as Dr. Samuel Brennan from GenieUS , shares about Amyotrophic lateral sclerosis (ALS) disease using multi-omic analysis. #ALS #Sporadic
Find more information & Register here: https://t.co/v4Ss3Y8AXL

[Invitrocue @Invitrocue]

Join us as Dr. Samuel Brennan from GenieUS , shares about Amyotrophic lateral sclerosis (ALS) disease using multi-omic analysis. #ALS #Sporadic
Find more information & Register here: https://t.co/v4Ss3Y8AXL

[Invitrocue @Invitrocue]

We hope the Webinar [New Trends in Drug Discovery: Robotics and AI ] has been insightful. Please keep a look out as we update on the next Webinar or Conference !

[Invitrocue @Invitrocue]

RT @Invitrocue: Join us at 3pm (Singapore Time) today as we learn about how automation and machine learning applications in drug discovery process ! #AI #Robotics #Drugdiscovery
Register here: https://t.co/7xH2nBGgDl

[Invitrocue @Invitrocue]

Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process.#AI #Robotics #Drugdiscovery
Register here: https://t.co/7xH2nBGgDl

[Invitrocue @Invitrocue]

Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process.#AI #Robotics #Drugdiscovery
Register here: https://t.co/7xH2nBGgDl

[Invitrocue @Invitrocue]

Invitrocue to establish Joint Venture in Brazil with commitment to offer thousands of patient tests | Learn more: https://t.co/YbDW7euV6p

[Invitrocue @Invitrocue]

"The war against cancer will be fought better with improved decision making tools" Read how Invitrocue is helping doctors make better decisions regarding treatment options | Nick Sundich reports for Stockhead: https://t.co/0FF0g5ymnF

[Invitrocue @Invitrocue]

Invitrocue establishes Hong Kong laboratory | Learn more: https://t.co/wASpnpGCMJ $IVQ

[Invitrocue @Invitrocue]

Invitrocue clinical validation studies underway in Germany | Learn more: https://t.co/BlGSeDQJkP $IVQ

[Invitrocue @Invitrocue]

Invitrocue Limited (ASX:IVQ) is an innovative life sciences company that specialises in developing ground-breaking 3D cell-based models from tumor tissues | Learn more: https://t.co/loax4kWY8H $IVQ

[Invitrocue @Invitrocue]

"There’s no question of demand for Onco-PDO at a macro level, with 15 million new cancer
cases a year and this number is expected to double by 2040" | Read Biotech Daily's Market Report featuring Invitrocue here: https://t.co/xN00aiRgyp